Compare SPCE & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCE | LAB |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.6M | 271.0M |
| IPO Year | 2017 | 2008 |
| Metric | SPCE | LAB |
|---|---|---|
| Price | $3.21 | $0.73 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $3.06 | $1.35 |
| AVG Volume (30 Days) | ★ 5.0M | 1.4M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.84 | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | $1,544,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $2,270.73 | N/A |
| Revenue Next Year | $880.03 | $2.63 |
| P/E Ratio | ★ N/A | $2.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $0.63 |
| 52 Week High | $8.90 | $1.72 |
| Indicator | SPCE | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 51.97 |
| Support Level | $2.83 | $0.70 |
| Resistance Level | $3.29 | $1.02 |
| Average True Range (ATR) | 0.17 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 64.65 | 60.71 |
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.